Vidya Perera, Zhaoqing Wang, Joseph Luettgen, Danshi Li, Mary DeSouza, Michael Cerra, & Dietmar Seiffert. (2022). First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor. Wiley.
Chicago Style (17th ed.) CitationVidya Perera, Zhaoqing Wang, Joseph Luettgen, Danshi Li, Mary DeSouza, Michael Cerra, and Dietmar Seiffert. First‐in‐human Study of Milvexian, an Oral, Direct, Small Molecule Factor XIa Inhibitor. Wiley, 2022.
MLA (9th ed.) CitationVidya Perera, et al. First‐in‐human Study of Milvexian, an Oral, Direct, Small Molecule Factor XIa Inhibitor. Wiley, 2022.
Warning: These citations may not always be 100% accurate.